Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelial cells

Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelial cells

Play all audios:

Loading...

ABSTRACT 1887 _Pulmonary Vascular Biology Platform, Monday, 5/3_ Prostacyclin is a critical mediator of vascular function and growth in the developing lung, where it is produced primarily by the vascular endothelium. A variety of studies in intact animal models indicate that prostacyclin plays a key role in the acute vasodilation of the pulmonary circulation at the time of birth. This is occurring at a time when fetal plasma estrogen levels are rapidly rising due to marked enhancement in placental estrogen synthesis following the onset of parturition. We have previously demonstrated that physiologic levels of estradiol (10-10 to 10-8M) stimulate the production of the vasodilator nitric oxide by ovine fetal pulmonary artery endothelial cells (PAEC). The present studies were designed to determine if estradiol acutely activates prostacyclin production in PAEC. Early passage cells were incubated for 5 to 30 min. in the presence of varying concentrations of 17β-estradiol, and prostacyclin synthesis was determined by radioimmunoassay for 6-keto-prostaglandin F1α, the stable metabolite of prostacyclin. 17β-Estradiol caused a 52% increase in prostacyclin synthesis compared to basal levels (256±30 vs 167±16 pg/well, respectively). The response was evident at 10-10M 17β-estradiol, and it occurred within 5 min of exposure to the hormone. There was no change in prostacylin production in response to 17α-estradiol (10-8 to 10-6M), indicating that the effect is unique to 17β-estradiol. Immunoblot analysis revealed comparable cyclooxygenase type 1 expression and a lack of cyclooxygenase type 2 in control and stimulated cells, signifying that the rapid response is not due to changes in the abundance of the rate-limiting enzyme in prostacyclin synthesis. Thus, the acute mechanism differs significantly from the effects of prolonged 17β-estradiol exposure, which we have previously shown upregulates cyclooxygenase type 1 mRNA and protein expression after 48 h. To determine the potential role of estrogen receptors (ER) in the rapid activation of prostacyclin production, studies were performed in the absence or presence of the ER antagonist ICI 182,780 (10-5M). Concomitant acute treatment with the ICI compound completely prevented 17β-estradiol-induced increases in prostacyclin production. RT-PCR assays and immunoblot analysis revealed expression of the alpha isoform of ER in the PAEC, whereas expression of the beta isoform was not detected. These findings indicate that physiologic concentrations of estradiol cause rapid stimulation of prostacyclin synthesis in fetal PAEC, and that this process is mediated by ER activation. The response most likely involves ERα, but further experiments will be required to exclude the potential role of a previously unknown ER subtype. These mechanisms may underly estrogen-induced vasodilation in both pulmonary and nonpulmonary vascular beds. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Dept. of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX Todd S Sherman, Ken L Chambliss, Margaret C Pace & Philip W Shaul Authors * Todd S Sherman View author publications You can also search for this author inPubMed Google Scholar * Ken L Chambliss View author publications You can also search for this author inPubMed Google Scholar * Margaret C Pace View author publications You can also search for this author inPubMed Google Scholar * Philip W Shaul View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Sherman, T., Chambliss, K., Pace, M. _et al._ Estrogen Acutely Activates Prostacyclin Synthesis in Ovine Fetal Pulmonary Artery Endothelial Cells. _Pediatr Res_ 45, 320 (1999). https://doi.org/10.1203/00006450-199904020-01903 Download citation * Issue Date: 01 April 1999 * DOI: https://doi.org/10.1203/00006450-199904020-01903 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

ABSTRACT 1887 _Pulmonary Vascular Biology Platform, Monday, 5/3_ Prostacyclin is a critical mediator of vascular function and growth in the developing lung, where it is produced primarily by


the vascular endothelium. A variety of studies in intact animal models indicate that prostacyclin plays a key role in the acute vasodilation of the pulmonary circulation at the time of


birth. This is occurring at a time when fetal plasma estrogen levels are rapidly rising due to marked enhancement in placental estrogen synthesis following the onset of parturition. We have


previously demonstrated that physiologic levels of estradiol (10-10 to 10-8M) stimulate the production of the vasodilator nitric oxide by ovine fetal pulmonary artery endothelial cells


(PAEC). The present studies were designed to determine if estradiol acutely activates prostacyclin production in PAEC. Early passage cells were incubated for 5 to 30 min. in the presence of


varying concentrations of 17β-estradiol, and prostacyclin synthesis was determined by radioimmunoassay for 6-keto-prostaglandin F1α, the stable metabolite of prostacyclin. 17β-Estradiol


caused a 52% increase in prostacyclin synthesis compared to basal levels (256±30 vs 167±16 pg/well, respectively). The response was evident at 10-10M 17β-estradiol, and it occurred within 5


min of exposure to the hormone. There was no change in prostacylin production in response to 17α-estradiol (10-8 to 10-6M), indicating that the effect is unique to 17β-estradiol. Immunoblot


analysis revealed comparable cyclooxygenase type 1 expression and a lack of cyclooxygenase type 2 in control and stimulated cells, signifying that the rapid response is not due to changes in


the abundance of the rate-limiting enzyme in prostacyclin synthesis. Thus, the acute mechanism differs significantly from the effects of prolonged 17β-estradiol exposure, which we have


previously shown upregulates cyclooxygenase type 1 mRNA and protein expression after 48 h. To determine the potential role of estrogen receptors (ER) in the rapid activation of prostacyclin


production, studies were performed in the absence or presence of the ER antagonist ICI 182,780 (10-5M). Concomitant acute treatment with the ICI compound completely prevented


17β-estradiol-induced increases in prostacyclin production. RT-PCR assays and immunoblot analysis revealed expression of the alpha isoform of ER in the PAEC, whereas expression of the beta


isoform was not detected. These findings indicate that physiologic concentrations of estradiol cause rapid stimulation of prostacyclin synthesis in fetal PAEC, and that this process is


mediated by ER activation. The response most likely involves ERα, but further experiments will be required to exclude the potential role of a previously unknown ER subtype. These mechanisms


may underly estrogen-induced vasodilation in both pulmonary and nonpulmonary vascular beds. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Dept. of Pediatrics, University of Texas


Southwestern Medical Center, Dallas, TX Todd S Sherman, Ken L Chambliss, Margaret C Pace & Philip W Shaul Authors * Todd S Sherman View author publications You can also search for this


author inPubMed Google Scholar * Ken L Chambliss View author publications You can also search for this author inPubMed Google Scholar * Margaret C Pace View author publications You can also


search for this author inPubMed Google Scholar * Philip W Shaul View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and


permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Sherman, T., Chambliss, K., Pace, M. _et al._ Estrogen Acutely Activates Prostacyclin Synthesis in Ovine Fetal Pulmonary Artery Endothelial


Cells. _Pediatr Res_ 45, 320 (1999). https://doi.org/10.1203/00006450-199904020-01903 Download citation * Issue Date: 01 April 1999 * DOI: https://doi.org/10.1203/00006450-199904020-01903


SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to


clipboard Provided by the Springer Nature SharedIt content-sharing initiative